| Biotechnology Industry | Healthcare Sector | Byeong-gwan Son CEO | KRX SM Exchange | - ISIN |
| KR Country | - Employees | - Last Dividend | 19 May 2026 Last Split | - IPO Date |
SCM Lifescience Co., Ltd., established in 2014 and based in Incheon, South Korea, is a biotechnology company engaged in various sectors of the healthcare and beauty industry. Its focus areas encompass stem cell therapy, where it pioneers in allogeneic stem cell therapeutics leveraging innovative stem cell isolation technology. This technology facilitates the development of treatments for immunological conditions and the regeneration of tissues by conducting extensive clinical trials. Beyond its primary research focus, SCM Lifescience also extends its expertise to Contract Manufacturing Organization (CMO) services, contract research, consulting, and the cosmetics industry, emphasizing skin cell science. Through these diverse operations, the company aims to contribute significantly to the medical and cosmetic fields by harnessing the potential of stem cells.
SCM Lifescience is dedicated to the development of groundbreaking allogeneic stem cell treatments using proprietary stem cell isolation technology. These therapeutics are primarily aimed at addressing a wide range of immunological conditions and promoting tissue regeneration, with ongoing clinical trials to ensure efficacy and safety.
The company offers comprehensive Contract Manufacturing Organization services to support the biotech industry. These services encompass the spectrum of manufacturing control, ensuring stringent quality assurance tests. By offering these CMO services, SCM Lifescience plays a crucial role in facilitating the production and distribution of biotech products.
SCM Lifescience extends its expertise to provide contract research services, contributing to the scientific community's effort to advance in the field of stem cells. Additionally, it offers consulting services, helping other organizations to navigate the complexities of biotechnological research and product development.
In the realm of cosmetics, the company focuses on skin cell science, offering a range of services and products designed to leverage stem cell technology for skin health and rejuvenation. This segment underscores SCM Lifescience's commitment to applying its biotechnological advancements not just in therapeutics but also in enhancing personal care and beauty products.